Isolation and structural determination of squalene synthase inhibitor from Prunus mume fruit

Journal of Microbiology and Biotechnology

Volumn 17, Issue 12, 2007, Pages 1970-1975

  Choi, Sung Won ^a   Hur, Nam Yoon ^a   Ahn, Soon Cheol ^b   Kim, Dong Seob ^c   Lee, Jae Kwon ^d   Kim, Dae Ok ^e   Park, Seung Kook ^e   Kim, Byung Yong ^e   Baik, Moo Yeol ^e  

^a Osan University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Pusan National University   (South Korea)

^d Kyonggi University   (South Korea)

^e Kyung Hee University   (South Korea)

Author keywords

Chlorogenic acid; Hypercholesterolemia; Prunus mume; Squalene synthase inhibitor

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; CHLOROGENIC ACID; PLANT EXTRACT; PRUNUS MUME EXTRACT; SILICA GEL; SQUALENE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CRYSTALLIZATION; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HYPERCHOLESTEROLEMIA; IC 50; LIVER; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PRUNUS; PRUNUS MUME; SWINE; ULTRAVIOLET SPECTROPHOTOMETRY;

CHLOROGENIC ACID; ENZYME INHIBITORS; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; FRUIT; INHIBITORY CONCENTRATION 50; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PRUNUS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET;

ANIMALIA; PRUNUS MUME; SUIDAE;

EID: 38149037027     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Abe, I., J. C. Tomesch, S. Wattanasin, and G. D. Prestwich. 1993. Inhibitors of squalene biosynthesis and metabolism. Nat. Prod. Rep. 11: 279-293.
2. Agnew, W. S. 1985. Squalene synthetase. Methods Enzymol. 110: 359-375.
3. Baxter, A., B. J. Fitzgerald, J. L. Hutson, A. D. McCarthy, J. M. Motteram, B. C. Ross, M. Sapra, M. A. Snowden, N. S. Watson, R. J. Williams, and C. Wright. 1992. Squalestatin, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. J. Biol. Chem. 267: 11705-11708.
4. Bergstrom, J. D., M. M. Krutz, D. J. Rew, A. M. Amend, J. D. Karkas, R. D. Bostedor, V. S. Bansal, C. Dufresns, F. L. V. Middleworth, O. D. Hensens, J. M. Liesch, D. L. Zinc, K. E. Wilson, J. Onishi, J. A. Milligan, G. Bills, L. Kaplan, M. O. Nallin, R. G. Jenskins, L. Huang, M. S. Meinz, L. Quinn, R. U. Burg, Y. L. Kong, S. Mochales, M. Mojena, I. Martin, F. Pelaez, M. T. Diez, and A. W. Albert. 1993. Zaragozic acids: A family of metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci USA 90: 80-89.
5. Biller, S. A., C. Forster, E. M. Gordon, T. Harrity, L. C. Rich, J. Marretta, and C. P. Ciosek. Jr. 1991. Isoprenyl phosphinylformates: New inhibitors of squalene synthetase. J. Med. Chem. 34: 1912-1914.
6. Cho, J.-Y., G. J. Choi, S.-W. Lee, K. S. Jang, H. K. Lim, C. H. Lim, S. O. Lee, K. Y. Cho, and J.-C. Kim. 2006. Antifungal activity against Colletotrichum spp. of curcuminoids isolated from Curcuma longa L. rhizomes. J. Microbiol. Biotechnol. 16: 280-285.
7. Cho, J.-Y., J.-H. Moon, H.-K. Kim, S.-J. Ma, S.-J. Kim, M.-Y. Jang, K. Kawazoe, Y. Takaishi, and K.-H. Park. 2006. Isolation and structural elucidation of antimicrobial compounds from buckwheat hull. J. Microbiol. Biotechnol. 16: 538-542.
8. Choi, S. W., D. S. Kim, N. Y. Hur, C. S. Park, and M. Y. Baik. 2003. Purification and identification of squalene synthase inhibitor isolated from fermented soybean paste. Food Sci. Biotechnol. 14: 89-93.
9. Dawson, M. J., J. E. Farthing, P. S. Marshall, R. F. Middleton, M. J. O'Neill, A. Shuttleworth, C. Stylli, R. M. Tait, P. M. Taylor, H. G. Wildman, A. D. Buss, D. Langley, and M. V. Hayes. 1992. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiot. 45: 639-647.
10. Feng, R., Y. Lu, L. L. Bowman, Y. Qian, V. Castranova, and M. Ding. 2005. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 280: 27888-27895.
11. Ha, C. G., J. K. Cho, C. H. Lee, Y. G. Chai, Y. A. Ha, and S. H. Shin. 2006. Cholesterol lowering effect of Lactobacillus plantarum isolated from human feces. J. Microbiol. Biotechnol. 16: 1201-1209.
12. Haria, M. and D. Mctavish. 1997. Pravastatin. Drugs 53: 299-336.
13. Hiyoshi, H., M. Yanagimachi, M. Ito, I. Ohtsuka, I. Yoshida, T. Saeki, and H. Tanaka. 2000. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: Comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. J. Lipid Res. 41: 1136-1144.
14. Hiyoshi, H., M. Yanagimachi, M. Ito, T. Saeki, I. Yoshida, T. Okada, H. Ikuta, D. Shinmyo, K. Tanaka, N. Kurusu, and H. Tanaka. 2001. Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism. Eur. J. Pharmacol. 431: 345-352.
15. Huh, S. J., K. H. Lee, H. S. Yun, D. J. Paik, J. M. Kim, and J. H. Youn. 2007. Functions of metallothionein generating interleukin-10-producing regulatory CD4+ cells potentiate suppression of collagen induced arthritis. J. Microbiol. Biotechnol. 17: 348-358.
16. Ishihara, T., H. Kakuta, H. Moritani, T. Ugawa, S. Sakamoto, S. Tsukamoto, and I. Yanagisawa. 2003. Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: Enzyme inhibition and effects on plasma lipid levels. Bioorg. Med. Chem. 11: 3735-3745.
17. Jee, H. J. 1999. Health Foods from Herbs, p. 52. Seoul National University Press, Seoul, Korea.
18. Kasim, S. E., R. C. Leboeuf, S. Khilnani, L. Tallapaka, D. Dayanada, and L. C. Jenk. 1992. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. J Lipid Res. 33: 1-7.
19. Keller, R. K. and F. Vilsaint. 1993. Regulation of isoprenoid metabolism in rat liver: Near constant chain lengths of dolichy phosphate and ubiquinone are maintained during greatly altered rates of cholesterogenesis. Biochim. Biophy. Acta 1170: 20-25.
20. Koo, K.-C., D.-H. Lee, J.-H. Kim, H.-E. Yu, J.-S. Park, and J.-S. Lee. 2006. Production and characterization of antihypertensive angiotensin I-converting enzyme inhibitor from Pholiota adiposa. J. Microbiol. Biotechnol. 16: 757-763.
21. Kuswik, R. G. and H. C. Rilling. 1987. Squalene synthetase. Solubilization and partial purification of squalene synthetase, copurification of presqualene pyrophosphate and squalene synthetase activities. J. Biol. Chem. 262: 1505-1510.
22. Lim, Y.-H., I.-H. Kim, J.-J. Seo, and J.-K. Kim. 2006. Tyrosinase inhibitor from the flowers of Impatiens balsamina. J. Microbiol. Biotechnol. 16: 1977-1983.
23. Lipid Research Clinics. 1984. Lipid research clinics program. J. Am. Med. Assoc. 252: 2545-2548.
24. McClellan, K. J., L. R. Wiseman, and D. McTavish. 1998. Cerivastatin. Drugs 55: 415-422.
25. Nardini, M., F. Natella, V. Gentili, M. Di-Felice, and C. Scaccini. 1997. Effect of caffeic acid dietary supplementation on the antioxidant defense system in rat: An in vivo study. Arch. Biochem. Biophys. 342: 157-160.
26. Nishimoto, T., Y. Amano, R. Tozawa, E. Ishikawa, Y. Imura, H. Yukimasa, and Y. Sugiyama. 2003. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro. Br. J. Pharmacol. 139: 911-918.
27. Park, J. K., H. J. Cho, Y. H. Lim, Y. H. Cho, and C. H. Lee. 2002. Hypocholesterolemic effect of CJ90002 in hamsters: A potent inhibitor for squalene synthase from Paeonia moutan. J. Microbiol. Biotechnol. 12: 222-227.
28. Poulter, C. D. 1991. Biosynthesis of non-head-to-tail terpenes. Formation of l′-1 and 1′-3 linkages. Acc. Chem. Res. 23: 70-77.
29. Poulter, C. D. and H. C. Rilling. 1981. Biosynthesis of Isoprenoid Compounds, pp. 413-441. Wiley Publisher, New York, U.S.A.
30. Rodriguez, de Sotillo D. V. and M. Hadley. 2002. Chlorogenic acid modifies plasma and liver concentrations of cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem. 13: 717-726.
31. Shepherd, J., S. M. Cobbe, I. Ford, C. G. Isles, A. R. Lorimer, P. W. MacFarlane, J. H. McKillop, and C. J. Packard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307.
32. Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389.